News

The trial is designed to evaluate the safety and efficacy of sustained erythropoietin (EPO) therapy delivered via the company’s EPODURE Biopump for the treatment of anemia in dialysis

IMO-3100 is an immunomodulator that inhibits the activity of TLR7 and TLR9 and modulates the production of multiple pro-inflammatory mediators. The randomized, double-blind, and placebo-controlled study is designed

The GSK gains exclusive access to FivePrime’s drug discovery platforms in up to six programs to identify first-in-class agents and new mechanisms relevant to refractory asthma and chronic

Biota will establish the US manufacturing of laninamivir, optimize its manufacturing processes, and conduct clinical trials for safety and efficacy in adult and pediatric populations. AMRI will initially

Azul Instant is an all-natural supplement for erectile dysfunction (ED) developed by the company as an alternative to prescription drugs. The addition of these two distributors will allow

The new solution will support the new XEVMPD submission standard, which goes into effect on 2 July 2012. The new XEVMPD regulation mandates that life sciences firms use

BioClinica customers will make use of Paragon’s resources to carry large-scale integration of BioClinica’s eClinical solutions across technology partnerships and client implementations. The Paragon partnership unites BioClinica’s OnPoint

The technology eliminates sample preparation steps in addition to the need for front-end gas or liquid chromatography separation. With the AxION DSA system, sample preparation time is now

VistaGen will utilize the licensed technology to develop hematopoietic precursor stem cells from human pluripotent stem cells, to develop drug screening and cell therapy applications for human blood